Search

Search Constraints

You searched for: Author/Creator Ohlmann, P

Search Results

1. 4283Impact of primary hemostasis disorders on late (>30 days) major/life-threatening bleedings after TAVR. (28th August 2018)

2. Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction. (25th November 2020)

3. Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality. (25th November 2020)

4. P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement. (25th November 2020)

5. P4490Quality matters: classification of centres by quality of care in acute myocardial infarction using the ESC-Acute Cardiac Care Association quality indicators. (28th August 2018)

7. P832Temporal changes in quality of care for acute myocardial infarction and relation with 1 year survival: acute cardiac care association quality indicators applied to the FAST-MI registries. (28th August 2018)

8. P973Impact of existing or new-onset atrial fibrillation in a setting of acute myocardial infarction. Insights from the FAST-MI 2005, 2010 and 2015 registries. (28th August 2018)

10. Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement. (14th October 2021)